Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Prostate Cancer and PSMA PET/CT.

Created on 17 Nov 2026

Authors

Begum Arca, Yasemin Sanli

Published in

Magnetic resonance imaging clinics of North America. Volume 35. Issue 1. Pages 91-99. Epub Oct 14, 2026.

Abstract

This review provides a comprehensive overview of prostate-specific membrane antigen (PSMA) PET/computed tomography (CT) in the management of prostate cancer. It explores the physiologic biodistribution of various 68 Ga and 18F-labeled tracers, standardized imaging protocols, and essential diagnostic criteria. We detail the modality's transformative role in primary staging, localizing biochemical recurrence at low prostate-specific antigen levels, and selecting patients for radioligand therapy. By highlighting critical diagnostic pitfalls and the emerging challenge of PSMA-negative disease, this article equips clinicians with the practical knowledge necessary to integrate PSMA PET/CT effectively into multidisciplinary oncology practice.

PMID:
43039506
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement